Market Research Blog – Page 3035 – New Product Development

Global Point of Care Molecular Diagnostics Industry Expects to Grow at a 9.7% CAGR to Reach a Surging US$11.1 Billion Market by 2033 | FMI

The Global Point of Care Molecular Diagnostics Industry is poised for a surge in growth, according to a recent market analysis by Future Market Insights (FMI). With a projected valuation of US$4.4 billion in 2023, the market is expected to experience significant expansion, reaching a staggering US$11.1 billion by 2033. This translates to a robust Compound Annual Growth Rate (CAGR) of 9.7% over the next decade.

The extraordinary trajectory of this industry indicates a growing demand for point-of-care molecular diagnostics, which is being driven by the increasing prevalence of infectious and chronic diseases. Cardiovascular disease, diabetes, and the continued issues posed by COVID-19 have all contributed to the increased demand for rapid and precise diagnostic treatments.

Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-14279

The growing advanced technology, diagnostic tests, preventive medicine, and knowledge of molecular mechanisms are driving the market growth. Furthermore, the adoption of the Global Point of Care Molecular Diagnostics Industry by laboratory specialists for sequencing DNA & multi-gene is expanding the market size. These diagnostics rapidly show the results with accuracy and are estimated to increase the sales of point-of-care molecular diagnostics.

Increasing respiratory, gastrointestinal, and sexually transmitted diseases are advancing the market growth. Emerging economies, government initiatives, and low-cost POC molecular diagnostics are the prime factors that propel market opportunities.

Factors Restraining the Global Point of Care Molecular Diagnostics Industry Growth

The market is going through a growth decline due to a few factors which are given below:

The dearth of consciousness about healthcare products, and poor penetration of advanced healthcare devices restrain market growth. The unavailability of advanced devices and the absence of government policies must gain market growth in developing countries.

Which Technology Category Booms the Global Point of Care Molecular Diagnostics Industry Growth?

The RT-PCR category dominates the global market with its remarkable CAGR of 9.2% during the foreseen time. The adoption of RT-PCR is rising due to the rise in tests such as genomics, COVID-19, proteomics, and others. It is a real-time system that shows results immediately, has high sensitivity, and costs efficiently. Due to the significant growth of infectious patients, healthcare providers are accelerating the demand for RT-PCR to provide patients with relevant data immediately.

Global Point of Care Molecular Diagnostics Industry Key Takeaways:

The Global point-of-care Molecular Diagnostics Industry is expected to have a valuation of US$ 11.1 billion by 2033.
With a CAGR of 9.7%, the global market will increase from 2022 to 2033.
The United States market is anticipated to capture a CAGR of 9.5% through 2033.
With a CAGR of 8.8%, the United Kingdom market significantly uplifts during the forecast period.
China’s market is expected to expand at a CAGR of 9.1% over the forecast period.
Japan’s market is likely to capture a CAGR of 8.2% from 2023 to 2033.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14279

Who is winning?

Key players fragment the global market by contributing an impressive role. These players are bringing new ideas and adapting them to build advanced products, which in turn surging market opportunities. Growing technologies, including Artificial Intelligence and the Internet of Things, have surpassed market growth in recent years.

By accepting these technologies, key players welcome better detection machines and equipment as per patients’ requirements. They further follow several effective marketing strategies such as partnerships, mergers, acquisitions, agreements, and product launches.

Recent Developments in the Global Point of Care Molecular Diagnostics Industry:

In Feb 2022, Sense Biodetection signed an agreement with Una Health to distribute COVID-19 testing equipment.
In Dec 2021, FIND Company invested a valuation of US$ 21 million in S.D. Biosensor, Biomeme, Quaife, and Bioneer for manufacturing, developing, and launching an affordable COVID-19 testing detector.
A healthcare provider BioMérieux agreed to partner with Africa Medical Supplies Platform in Oct 2020 to supply premium quality COVID-19 diagnostic solutions.
Abbott Laboratories announced its new COVID-19 detection product which can deliver results within minutes, in March 2020.
In Oct 2018, QIAGEN agreed to enhance its portfolio with STAT-Dx to provide its customers with a next-generation PCR system.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/14279

Global Point of Care Molecular Diagnostics Industry Segmentation by Category

By Products & Services:

Assays & Kits
Instruments &Analyzers
Software & Services

By Technology:

RT-PCR
INAAT
Other Technologies

By Application:

Respiratory Diseases
Sexually Transmitted Diseases
Hospital-acquired Infections
Cancer
Hepatitis
Gastrointestinal Disorders
Other Applications

By End User:

Physicians’ Offices
Hospitals & ICUs
Research Institutes
Other End Users

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Sepsis Diagnostics Industry is expected to grow at an astounding 8.1% CAGR and reach targets of over US$ 1.2 Billion by 2033 | According to FMI

The Global Sepsis Diagnostics Industry is on an upward trajectory, according to a recent market analysis by Future Market Insights. Currently valued at US$561.2 million in 2023, the market is expected to experience robust growth at a Compound Annual Growth Rate (CAGR) of 8.1% over the next decade, reaching an impressive US$1.2 billion by 2033.

Several variables are driving demand for sepsis diagnostics, contributing to this large increase. The growing prevalence of antibiotic-resistant bacterial strains, a rapidly aging global population, and an increase in hospital-acquired illnesses have heightened the demand for better diagnostic solutions. Notably, the spike in product approvals for sepsis diagnosis is projected to drive up demand for cutting-edge diagnostics in the industry.

Despite the optimistic trajectory, the industry faces challenges that warrant attention. The shortage of experienced specialists for sepsis diagnosis poses a notable obstacle, compounded by a lack of awareness and the persistent reliance on conventional processes during antibiotic production, all identified as factors impacting the sales of sepsis diagnostics.

However, the market’s potential is buoyed by positive indicators in developing markets. The increasing incidence of newborn umbilical cord infections and a rise in surgical procedures in these regions provide a favorable landscape for the growth of sepsis diagnostics.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14272

HAIs, also known as nosocomial infections, are a leading source of morbidity and mortality in hospitals around the world. Urinary tract infections, pneumonia, and sepsis are the most frequent hospital-acquired infections (HAIs). In addition, in immunocompromised individuals, aged patients, and people with chronic conditions, HAIs can cause sepsis. Because of the significant rise in HAIs around the world, demand for sepsis diagnostic devices is projected to expand in the future years.

Sepsis is a complex condition to detect, and even a one-minute delay in antibiotic delivery increases the chance of death by 7.6% in septic shock patients with hypertension. As a result of the emerging trends in the Global Sepsis Diagnostics Industry, there is a greater need for quick sepsis detection to avoid antibiotic therapy delays in sepsis patients.

Many sepsis diagnostic companies are growing their product offerings in point-of-care technologies, which can quickly identify sepsis, cut down on diagnosis time, and improve life expectancy after sepsis.

Key Takeaways from the Global Sepsis Diagnostics Industry

Attributed to the presence of a larger consumer population in developing markets such as India and China, the Asia Pacific region of rapid sepsis diagnostics is expected to grow profitably over the forecast period.
The Global Sepsis Diagnostics Market adoption trends indicate North America is likely to generate more than $200 million in revenue by the end of 2026. The sepsis diagnostics companies in the region are growing due to well-established healthcare infrastructure and increased usage of innovative products. Septic poisoning is also one of the leading causes of death in the United States.
As per the sepsis diagnostics market analysis, microbiology technology is likely to gain traction. Microbiology is expected to generate more than $200 million in income by 2026.
By product, the sepsis diagnostics market opportunities are divided into blood culture media, assays & reagent kits, devices, and software. The blood culture media segment held the most significant market share during the forecast period. This growth can be ascribed to a rise in blood culture media as a sepsis diagnostics device.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-14272

“Sepsis diagnostics devices are expensive, limiting the growth of this industry. Additionally, in certain countries, there are no clear guidelines for the treatment of sepsis, and there is a lack of awareness about the repercussions of sepsis if it is not treated effectively.”

Competitive Landscape Organizations in the global quality articulation market are consolidating and acquiring systems to gain a competitive advantage and generate significant profits. On the other hand, some players benefit from significant new work systems to gain a competitive advantage in the Global Sepsis Diagnostics Industry statistics.

Cytovale Inc. and the Biomedical Advanced Research and Development Authority, or BARDA, announced cooperation in April 2020 to increase the use of Cytovale’s Rapid Sepsis Diagnostic System for identifying sepsis in patients with probable respiratory infections, such as COVID-19.
Immunexpress announced a quick SeptiCyte, a one-hour molecular diagnostic test for sepsis, on Biocartis’ Idylla platform in Europe in October 2020. This is one of the first deeply integrated, immune response-based diagnostics to help clinicians diagnose sepsis and Global Sepsis Diagnostics Industry analysis.

Global Sepsis Diagnostics Industry Key Segments

By Product:

Blood Culture Media
Assays & Reagents
Instruments, and Software

By Technology:

Blood Culture
Immunoassays
Molecular Diagnostics
Flow Cytometry
Microfluidics
Biomarkers

By Method:

Automated Diagnostics
Conventional Diagnostics

By Pathogen:

Bacterial Sepsis
Fungal Sepsis
Viral Sepsis
Others

By Test Type:

Laboratory Tests
Point-of-Care Tests

By End User:

Hospitals and Specialty Clinics
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/14272

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Stoma Ostomy Care Industry to Grow at a Consistent 4.9% CAGR to Reach US$6.5 Billion by 2033 | FMI Study

The Global Stoma Ostomy Care Industry is experiencing a period of remarkable growth, according to a recent market analysis. Expected to reach US$3.8 billion by the end of 2022, the market is projected to maintain a steady trajectory, climbing at a Compound Annual Growth Rate (CAGR) of 4.9% from 2023 to 2033. This upward trend is anticipated to propel the industry to a valuation of US$6.5 billion by 2033.

Several significant factors contribute to the remarkable growth trajectory of the stoma care market. The increased prevalence of disorders that require ostomy care, combined with continual developments in surgical techniques and ostomy supplies, has played a critical part in accelerating this considerable expansion. Furthermore, increased awareness and advantageous reimbursement policies have provided a conducive atmosphere for the market’s continued expansion.

Among the most prevalent conditions requiring ostomy care are colorectal cancer, bladder cancer, and inflammatory bowel disease (IBD). These medical conditions often demand surgical intervention, such as surgical excision of aggressive melanoma of the intestine. In certain instances, patients require ostomy procedures, which involve the creation of a surgical incision through the abdomen to establish a new waste minimization conduit.

As we move forward, the stoma care market is poised to provide vital support and innovative solutions for individuals facing these medical challenges, contributing to improved healthcare outcomes and quality of life.

Request a Sample Copy of This Report Now.
https: www.futuremarketinsights.com reports sample rep-gb-14261

The adoption of stoma ostomy care procedures has increased worldwide due to the rising occurrence of these diseases and increased exposure to risk factors such as changing eating habits and increased antibiotic use in children.

However, despite recent advancements, the stoma ostomy market faces several constraints that limit its growth potential. These include stoma care issues, discomfort and other concerns associated with ostomy products, societal stigma, and increased acceptance of alternative therapies, particularly in developing countries.

While stoma surgeries are generally safe, there are some risks involved, including life-threatening issues such as necrosis and exhaustion. As a result, the acceptance of stoma care appliances may be limited to some extent.

Global Stoma Ostomy Care Industry Key Takeaways:

The USA market will hold a market share of around 28.7% in the 2023 global market.
Germany is set to hold around 5.3% of the global market share in stoma ostomy care in 2023.
The Indian market is projected to expand at a CAGR of 3.8% during the forecast period.
Due to a growing number of patients suffering from target diseases such as colorectal cancer, Ostomy Bags is predicted to occupy a considerable revenue share of 84.3% in the global market by 2023.
Due to the rising frequency of IBD, bowel cancer, and colon cancer in both developed and developing nations, as well as the favorable reimbursement environment in developed countries, the colostomy sector is predicted to hold a high market share of 88.8% in the global market in 2023.

“Improvement in product design will remain a key differentiator as end users have to face stigma with the drainage bags,” reports an FMI analyst.

Grab Your Discount Now Before It’s Gone!
https: www.futuremarketinsights.com request-discount rep-gb-14261

Global Stoma Ostomy Care Industry Competitive Landscape

The European market for stoma ostomy care is the largest. However, according to recent trends, key players are focusing on the Asia Pacific market due to low labor costs and a large pool of patients.

Coloplast Singapore released SenSura Mio in February 2022, which uses the latest elastic adhesive technology and is appropriate for all peristomal body profiles. SenSura® Mio is being offered in Singapore for the first time in Southeast Asia to improve the quality of life for ostomytes, or those who have had an ostomy and now have a stoma.
Trio Healthcare received financing from SWK Holdings Corporation, a specialized finance company based in the United States, in February 2020, to accomplish significant local and global expansion ahead of an anticipated product launch in 2021.

Key Players in the Global Stoma Ostomy Care Industry

BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc, 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc, Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG., Salts Healthcare Ltd, Securi–T USA., Welland Medical Limited, Flexicare Group Limited.

More Insights Available

North America is expected to dominate the stoma care market, owing to the high incidence of colorectal cancer and inflammatory bowel disease in the region, as well as the high adoption rate of advanced stoma care products. The United States is the largest market in North America, followed by Canada.

Get Your Customized Impactful Report Now!
https: www.futuremarketinsights.com customization-available rep-gb-14261

Global Stoma Ostomy Care Industry Key Segments

By Surgery Type:

Colostomy
Ileostomy
Urostomy

By Product:

Ostomy Bags
Ostomy Accessories
- Belts & Tapes
- Skin Protection &Skin Barrier
- Irrigation Sets
- Convex Inserts
- Stoma Caps

By Application:

Cancer
Inflammatory Bowel Disease
Bowel Obstruction
Fecal Incontinence
Trauma and Infection

By End–Users:

Hospitals and Specialty Clinics
Home Care Settings
Ambulatory Surgical Centers

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https: www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Peptide Synthesis Industry is expected to grow at an exceptional 8% CAGR and reach US$1.1 Billion in valuation by 2033 | FMI

The Global Peptide Synthesis Industry is on track for significant growth, according to a recent market analysis by Future Market Insights. The market, currently valued at an estimated US$520.0 million in 2023, is projected to climb steadily at a Compound Annual Growth Rate (CAGR) of 8%, reaching an impressive US$1.1 billion by 2033.

The rising prevalence of metabolic illnesses and chronic diseases such as diabetes, oncology, and obesity is driving this unprecedented growth. This development emphasizes the crucial need for novel medical solutions, with peptide synthesis emerging as a key component. Its broad chemical diversity, powerful biological activity, and low toxicity make it an ideal choice for the development of cutting-edge healthcare solutions.

The market’s expansion is further fueled by the escalating demand for pharmacological components in medication. As the need for treatments targeting cardiovascular, neurological, and renal failures continues to grow, the significance of peptide synthesis in the pharmaceutical landscape becomes increasingly evident.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14257

Governments’ initiative programs, advanced healthcare therapy with adopting the latest technology, and research and development activities are further surging the market opportunities.

Rising consumer healthcare and pharmaceutical sectors are increasing the demand for peptide synthesis. Moreover, the growing malignancies, uneven lifestyles, and deadly diseases propel market opportunities. Due to its effective result, the growing popularity of enzymatic technology upsurges market growth among patients.

How Key Players Faced Threats in the Global Peptide Synthesis Industry?

Due to the lack of a peptide purification system, several therapeutic peptides go through the parenteral route. The adoption of peptide synthesis medications is widely used to treat a chronic illness for a long period of treatment, may face a problem for key players. Enzymatic breakdown and limited intestinal mucosa are a few causes of adopting oral peptide drugs.

These medicines have poor lipophilicity and charged functional groups, which are difficult to handle or absorb. However, several peptide synthesis companies are given that peptides have short half-lives and limited bioavailability. Fast metabolism and conformational changes restrict protein therapies and the bioavailability of peptides.

Pharmaceutical and Biotechnology Sectors Leading the Market Growth

Growing research and development activities, low-cost therapies, and efficient and low toxicity are a few important factors that propel market growth. The significantly growing advanced technology in the pharmaceutical and biotechnology sectors is driving peptide synthesis market expansion.

In 2022, according to Science Direct, advanced oral drugs treated diabetes patients through peptide medications. Moreover, in Jan 2022, Novo Nordisk launched its new and world’s first diabetes management ‘peptide in a pill’.All these developments are boosting the pharmaceutical and biotechnology sectors.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14257

Increasing Patients of Chronic Disease Dominates the United States Market

The United States is leading the global market by capturing an impressive CAGR of 7.8% during the foreseen time. Increasing chronic patients, including cardiovascular and diabetes, are fostering market growth. The rising demand for peptide-based vaccines is increasing the demand for peptide synthesis.

According to a report by the American Cancer Society, around 1.9 million new cancer cases grew in the United States. The innovation of new drugs, rising government policies, and new market entrance are surging the United States peptide synthesis market opportunities.

Global Peptide Synthesis Industry Key Takeaways:

The peptide synthesis market is expected to have a valuation of US$ 1.1 billion by 2033.
With a CAGR of 8%, the global market increasing from 2022 to 2033.
The United States peptide synthesis market is anticipated to record a CAGR of 7.8% through 2033.
With a CAGR of 7.1%, the United Kingdom market significantly uplifts during the forecast period.
China’s market is expected to hold a CAGR of 7.4% over the forecast period.
Japan’s market captured a CAGR of 6.5% from 2023 to 2033.

Global Peptide Synthesis Industry Competitive Landscape:

The present prominent players fragmented the market. These players invested a huge amount in research and development activities to acquire maximum output. Through their marketing strategies, these prominent players upsurge the market growth.

Global Peptide Synthesis Industry Key Players:

GenScript Biotech Corporation
Bachem Holding AG
Thermo Fisher Scientific Inc
Merck KGaA
Kaneka Corporation

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/14257

Global Peptide Synthesis Industry Recent Developments:

In June 2020, Evonik announced its new peptide, which is highly soluble and chemically defined to supply amino acids.
In May 2022, the United States Food and Drug Administration approved the Mounjaro injection that helps to control blood sugar and type 2 diabetes disease.

Global Peptide Synthesis Industry by Category

By Product and Services:

Reagents
Equipment
Services

By Technology:

Solid-phase peptide Synthesis
Solution-phase Peptide Synthesis
Hybrid & Recombinant Technology

By End Use:

Pharmaceuticals & Biotechnology Companies
CDMOs & CROs
Academics & Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Medical Rehabilitation Robotics Industry is Projected to Grow at a 15.2% CAGR to Reach US$1.76 Billion by 2033 | FMI

The Global Medical Rehabilitation Robotics Industry is poised for significant growth, driven by advancements in technology and increasing demand for innovative solutions, according to a recent market analysis by Future Market Insights (FMI). Currently valued at US$366.2 million in 2022, the market is expected to climb steadily at a Compound Annual Growth Rate (CAGR) of 15.2%, reaching an impressive US$1.76 billion by 2033.

In combination with this expansion, the Pediatrics Rehabilitation Robotics Market, while still in its early phases, promises a promising future. The expansion of rehabilitation services for patients with diseases like autism and cerebral palsy is projected to be a key driver of market growth.

One of the highlights of medical rehabilitation robotics is its myriad of benefits, particularly in affording individuals with spinal cord injuries the opportunity to stand and walk at a reduced metabolic cost. Moreover, this industry is at the forefront of technological advancements, incorporating Machine Learning (ML) and Artificial Intelligence (AI) alongside advanced sensor technologies. The burgeoning geriatric population further propels the exponential growth of the medical rehabilitation robotics industry.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14242

Along the above-mentioned lines, PARO comes across as a companion robot that has been specially designed for those suffering from Alzheimer’s, dementia, and various other cognition disorders. Dr. Takanori Shibata from Japan’s National Institute of Advanced Industrial Science and Technology has come up with this assistive robot for helping those with disabilities fulfill daily activities like eating and walking.

The robotic lower-body exoskeleton is being used to assist the ones with paralysis of the lower limbs and does encourage muscle activity therein.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Medical Rehabilitation Robotics Market’ with its team of analysts and consultants deploying a 360-degree view in its primary, secondary, and tertiary modes of research.

“With Spike in cases of stroke, the global medical rehabilitation robotics industry is expected to go great guns shortly”, says an analyst from Future Market Insights.

Key Takeaways from the Global Medical Rehabilitation Robotics Industry

North America holds more than 40% of the market share due to growing incidences of spinal cord injury followed by a rising aging and disabled population.
Europe holds a significant market share with Germany leading from the front with Spain, Denmark, and the UK leading from the front.
The Asia-Pacific is expected to grow at a rapid pace in the medical rehabilitation robotics industry with countries like Japan obtaining the status of ‘super-aging society’.

Ask an Analyst Now.
https://www.futuremarketinsights.com/ask-question/rep-gb-14242

Competitive Robotics

Ekso Bionics Holdings, Inc. received approval from the US FDA for marketing the EksoNR robotic exoskeleton for usage with patients suffering from MS (Multiple Sclerosis).
Tyromotion, of late, completed the acquisition of band therapy AG (a Swiss-based start-up) to encourage patients’ ownership of recovery with cutting-edge movement trackers.
Bionik Laboratories Corporation, in January 2019, launched the InMotion ARM/HAND robotic system to clinically rehabilitate stroke survivors and the ones having mobility impairments owing to neurological conditions. The enhanced robotic system has been developed according to principles of motor learning as well as neuroplasticity and makes use of AI and data analysis for offering individualized therapy to patients.
ReWalk Robotics, Inc., in June 2019, announced that the US FDA approved the ReStore soft exo-suit system for selling to rehabilitation centers all over the US.
Cyberdyne Inc., in January 2018, obtained approval from the US FDA to sell HAL (Hybrid Assistive Limb) lower-body exoskeleton in licensed medical facilities all over the US.
Stryker Corporation, in the year 2020, did receive regulatory approval for the MAKO robotic surgery system in Japan for partial knee indication.
Accuracy, in 2020, did launch the CyberKnife S7 System, which comes across as a next-generation CyberKnife platform with real-time, advanced, AI-driven motion tracking as well as synchronization treatment delivery for SBRT (stereotactic body radiation therapy) and SRS (stereotactic radiosurgery).
Medtronic, in 2020, completed the acquisition of Medicrea through AI, patient-specific implants, and predictive modeling.
Intuitive Surgical, in 2019, did receive clearance from the US FDA regarding the da Vinci Single-port Surgical System.

Key Global Medical Rehabilitation Robotics Industry Players:

Ekso Bionics Holdings Inc.
AlterG Inc.
Bionik Laboratories Corp.
Cyberdyne Inc.
Rewalk Robotics.
Instead Technoligies Ltd.
Hocoma AG.
Fourier Intelligence
Tyromotion Gmbh
Toyota Motor Corporation
BeatBots LLC
Bioxtreme
Rex Bionics Inc.
LEADERS REHAB ROBOT Co. Ltd.

Click Here Today To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/14242

Key Segments Covered in Global Medical Rehabilitation Robotics Industry Research

By Product:

Exoskeletons
Therapeutic/ Assistive

By Extremity:

Upper Extremity
- Arm
- Wrist
- Shoulder
- Elbow
Lower Extremity

By Therapy:

Limb Mobility
Gait
Sensory

By Patient:

Adults
Pediatric

By Application:

Neurorehabilitation
Physical Rehabilitation
Others

By End-user:

Hospitals
Wellness centers
Rehabilitation centers
Homecare

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Cold Disposable Biopsy Forceps Industry is expected to grow at a rate of 8.2% and reach US$1.40 Billion by 2033 | FMI

According to a recent market analysis by Future Market Insights (FMI), the Global Cold Disposable Biopsy Forceps Industry is poised for significant growth. The market is on track to achieve impressive milestones, with a projected valuation of US$634.6 million by 2023. This marks the beginning of a steady growth trajectory, fueled by a compelling Compound Annual Growth Rate (CAGR) of 8.2%. By 2033, the market is expected to reach a substantial valuation of approximately US$1.40 billion.

The surge in demand for cold disposable biopsy forceps is attributed to several factors, including the increasing prevalence of bronchitis and gastrointestinal disorders, particularly among the geriatric population. Additionally, a heightened awareness of endoscopic procedures is contributing to the market’s upward trajectory. The adoption of disposable biopsy forceps, known for their reliability in test sampling, is also expected to gain widespread popularity.

The current landscape sees minimally invasive technology, centered around the endoscope system, extending its reach to various medical departments, including obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and more. Minimally invasive endoscopic technology has become indispensable for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and beyond.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14240

With the rising demand for endoscopic minimally invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

Key Takeaways from Global Cold Disposable Biopsy Forceps Industry Study

Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.
8 mm diameter has sharpened cups which ensure superior cutting performance and lead to fewer artifacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
2300 mm length forceps have precise jaws, no tearing, and cause small wounds. The segment accounted for the highest share of 37.9% in 2021.
Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

“High prevalence of conditions such as IBD and GERD and growing demand for minimally invasive endoscopic procedures are set to boost the demand for Global Cold Disposable Biopsy Forceps Industry over the next decade,” says the Future Market Insights analyst.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14240

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

iIn April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In july 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the Global Cold Disposable Biopsy Forceps Industry include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and other companies.

Key Market Segments Covered in Global Cold Disposable Biopsy Forceps Industry Research

By Product:

Oval Cup
Oval Cup with Needle
Alligator Jaw
Alligator Jaw with Needle

By Diameter Size:

By Length:

1150mm
1550mm
2300mm

By Application:

Enteroscopy
Upper GI Endoscopy
Lower GI Endoscopy
Bronchoscopy
Others

By End User:

Enteroscopy
Upper GI Endoscopy
Lower GI Endoscopy
Bronchoscopy
Others

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14240

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Manometry System Industry is expected to grow at a 5.4% CAGR and reach US$311.64 Million By 2033 | FMI

According to a recent market analysis, the Global Manometry System Industry is set for a period of solid growth. The market, currently projected to generate US$184.18 million in sales by 2023, is expected to climb steadily at a Compound Annual Growth Rate (CAGR) of 5.4%. With this consistent growth, the market is anticipated to reach an impressive US$311.64 million by 2033.

This phenomenal expansion is being driven by several significant variables influencing the landscape of the manometry system business. A large increase in the incidence of fecal incontinence and constipation, combined with an aging worldwide population, is driving the market’s increasing trend. Furthermore, continuing technical developments and ongoing healthcare infrastructure development are critical to the industry’s success.

The surge in cases related to constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia, and Hirschsprung’s among the elderly population is fueling the adoption of manometry systems. The increasing demand for these systems stems from their ability to evaluate patients, providing valuable data on anorectal function and indicating the prognosis of treatment, especially in managing sphincter injuries.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising demand for non-invasive equipment is driving the demand for manometry systems. These systems are non-invasive diagnostic procedures that can detect pressures and sensations in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of products are boosting the demand for the Global Manometry System Industry. Initiatives undertaken by the government to enable and boost the ecosystem for the indigenous medical device industry are also stimulating market growth.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from Global Manometry System Industry Study

By product, system sheaths & catheters are expected to account for the largest share of 0% in 2021.
In terms of portability, the stand-alone system will hold the largest share of 4 in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of the condition
By end user, hospitals accounted for the largest share of 9 in 2021 owing to the rising demand for hospital stays that is short-term and an increasing number of gastrointestinal processes.
North America is expected to hold the largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14110

Who is Winning?

Some of the leading manufacturers of the manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategies adopted by the leading players in the manometry system market. Following this, the acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand its regional presence as well as product offerings.

For instance,

In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in pediatric urology. The MBS was an innovative product of UROTECH GmbH, which is used in stent placement as well as stent removal of children without performing the surgeries using the stent’ magnetic tip.”
In May 2020, RMS Medical Devices proudly announced its acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
In October 2020, LABORIE Medical Technologies entered into a strategic partnership with Urotronic to support regulatory approval of Optilume, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).
In August 2021, Medtronic Announced the FDA Approval of the Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease of use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14110

Key Segments of the Global Manometry System Industry by Category

Product:

Anorectal Manometry System
Anorectal Manometry System Software
Anorectal Manometry System Sheath & Catheters

Portability:

Stand Alone System
Portable System

End User:

Hospitals
Diagnostic Centers
Specialty Clinics
Academic Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Nasal Antihistamines Industry is expected to reach US$3.23 Billion by 2033 at a 4.6% CAGR | According to FMI

According to a recent market analysis, the Global Nasal Antihistamines Industry is experiencing a remarkable growth trajectory. The market, currently valued at an estimated US$2.06 billion in 2023, is projected to climb steadily at a Compound Annual Growth Rate (CAGR) of 4.6%, reaching a significant milestone of US$3.23 billion by 2033.

Antihistamines, renowned for their effectiveness in alleviating allergy symptoms, have become a focal point in the pharmaceutical landscape. These medications play a pivotal role in addressing issues stemming from an excess of histamine—a natural substance produced by the immune system. Individuals suffering from allergies, particularly those triggered by pollen and various allergens, have wholeheartedly embraced antihistamines to find relief from symptoms such as sneezing, congestion, and itchy, runny noses.

Over the past three decades, the global prevalence of respiratory diseases—including allergic rhinitis, chronic obstructive pulmonary disease, and asthma—has surged. According to a report published by the National Center for Biotechnology Information (NCBI), approximately 20–30% of the Indian population grapples with allergic rhinitis, with 15% eventually developing asthma¹.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-13708

Due to this growing burden, there has been an increased adoption rate of nasal antihistamines in the form of nasal sprays and nasal drops, globally. The nasal antihistamines provide rapid and effective relief from the symptoms of allergic rhinitis. Thus, the growing number of allergic rhinitis cases will propel the growth of the Global Nasal Antihistamines Industry in the future.

Advancements in the field of nasal drug delivery have enabled the establishment of several non-invasive approaches for treatment. Various new products such as metered dose delivery systems, innovative odorless powders and sprays, preservative-free nasal sprays, and others are key drivers that will expand this industry in the forecast period.

FDA approvals of various nasal sprays to switch from prescription to OTC use has led to increased independence concerning the self-administration of drugs, among patients who suffer from allergic rhinitis. Various additions by the manufacturers to the already available product lines, especially for AR are some of the techniques used by the manufacturers to increase product penetration amongst the population.

New product launches & approvals have emerged as key growth strategies adopted by the leading players in the Global Nasal Antihistamines Industry. Following this, the acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand its regional presence as well as product offerings.

For instance, In December 2020, GlaxoSmithKline launched Otrivin Breathe Clean, a saline wash with the moisturizing benefit of natural glycerine as a product for the symptomatic relief of allergic rhinitis.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Key Takeaways from Global Nasal Antihistamines Industry Study

By product, nasal sprays accounted for the largest share of 89.0% in 2021 and are expected to continue to grow at the same trend during the forecast period.
By age group, adults accounted for the largest share in 2021 of the nasal antihistamines market and are expected to continue to grow at the same trend during the forecast period.
By distribution channel, the retail pharmacies segment is expected to account for the largest share of 41.0% in 2021 of the nasal antihistamines market and is expected to continue to grow at the same trend during the forecast period.
By region, East Asia held the largest share of 23.0% in 2021 of the nasal antihistamines market. The growing awareness regarding allergies and developing healthcare infrastructure are some of the factors that fuel the high market share of this region.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13708

Who is Winning?

Some of the leading manufacturers of the Global Nasal Antihistamines Industry are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In April 2021, Merck & Co. acquired Pandion Therapeutics, Inc which is a U.S. based clinical-stage biotechnology company for US $1.85 Bn. With this acquisition, Merck strategizes to identify and secure candidates with differentiated and potentially found characteristics for the clinical trials that would be required for their new product launches. This will ensure smooth conduction of clinical trials and thus help the company to expand their business.
In April 2020, Cipla received final approval for a generic version of Proventil® HFA Inhalation Aerosol, from the United States FDA. With this approval, the company strengthened their presence in the US pharmaceutical market

The key market players covered by FMI include Bayer Healthcare LLC, Novartis International AG, Cipla, Glenmark Pharmaceuticals, GlaxoSmithKline, Sun Pharmaceuticals, Merck & Co., Centaur Pharmaceuticals, Viatris (Meda Pharmaceuticals), Proctor & Gamble, Ascend Laboratories LLC (Alkem Laboratories), J Pharmaceuticals, Alistair Pharmaceuticals, and Sato Pharmaceuticals.

Global Nasal Antihistamines Industry by Category Product:

Nasal Spray
Nasal Drops

Age Group:

Adult
Pediatric

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores

Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/13708

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Lunchtime Gets Powered Up: The Electric Tiffin Market Plugs into a 4.40% CAGR by 2034

The electric tiffin market is likely to hold a valuation of US$ 1,782.30 million by 2034. As of 2024, the market value is US$ 1,157.40 million. As individuals worldwide seek convenient food storage options, the electric tiffin market is expected to expand by 4.40% from 2024 to 2034.

The rise in globalization and the increase in people moving to cities for jobs significantly raised the global marketplace’s demand for food storage appliances. Electric tiffins or lunchboxes are a convenient way to carry food items as consumers can regulate the temperature of their food items. It also enhances the taste of the food and keeps it fresh by increasing the overall shelf life.

Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-7941

Electric tiffin not only finds its place in the day-to-day lives of working professionals, but it has also started to gain significant impetus in college-going students. Bachelors living away from their families utilize electric tiffins to savor the natural taste of their delicacies without the need for advanced kitchen appliances.

With the advancements in technology and rising demand, there has been an influx of many features in the electric tiffin market. Smartphone connectivity, customizable temperature control, portion monitoring, etc., have all contributed to the growth of the electric tiffin market. Along with this, there is a noticeable incorporation of IoT services, like voice commands, automatic heating, etc., in the electric tiffins to enhance consumers’ overall experience.

“The market for electric tiffins is still in its nascent stages, where many people in developing and underdeveloped nations are still unaware of the benefits. Key players in the market have failed to penetrate the rural regions, which constitute a significant chunk of the population in countries like India, China, etc. Key companies have also started developing electric tiffins from sustainable materials to cater to the demands of eco-conscious consumers”, opines an FMI analyst.

Key Takeaways from the Electric Tiffin Market Report:

The electric tiffin market is expected to grow by 4.40% from 2024 to 2034.
Multi-layered tiffins dominate the global electric tiffin market, with an overall revenue share of 64.30%.
Regarding distribution channels, online platforms capture 56.30% of the global electric tiffin market revenue.
Spain is the leading market for electric tiffins, with a remarkable growth rate of 6.80% from 2024 to 2034.
Spain is followed by Australia (6.50%), India (6.40%), and Singapore (6.00%) in terms of electric tiffin market growth.

Competitive Analysis of the Electric Tiffin Market:

In the competitive landscape of the electric tiffin market, well-established international and local players are present. Key market players are primarily renowned kitchen appliance companies recognized for their reliability and brand reputation. Small businesses often struggle to sustain their presence due to the dominance of these established players. To maintain relevance in this competitive arena, these new entrants must introduce new technological features into their product offerings.

Global Electric Tiffin Market: Key Players

Some of the key players operating in the global Electric Tiffin market are Hamilton Housewares Pvt. Ltd. (Milton), Ecoline Appliances, Tayama Appliances USA Inc., Koolatron, Zojirushi America Corporation among others.

Recent Developments:

In 2022, Panasonic made headlines with the launch of the Panasonic Nano Ionic Steamer, a unique addition to the electric tiffin market. This innovative tiffin box features a Nano-ionic steam function that preserves food moisture and freshness.
Pigeon announced its new addition to the electric tiffin market, the Pigeon Handy Gourmet, with stainless steel construction and a temperature control feature. It offers consumers a stylish and convenient way to enjoy hot meals on the go.

Request the Full Report Methodology Now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7941

Market Segmentation

By Types:

Single-layered electric tiffin
Double-layered electric tiffin
Multi-layered electric tiffin

By Application:

Household
Commercial
Offices
Educational Institutions
Hospitality Industry
Foodservice Industry

By Distribution Channel:

Direct
Indirect
Hypermarket/Supermarket
Specialty Stores
Independent Stores
Online Store
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East and Africa

Author

Sneha Varghese (Senior Consultant, Consumer Products & Goods) has 6+ years of experience in the market research and consulting industry. She has worked on 200+ research assignments pertaining to Consumer Retail Goods.

Her work is primarily focused on facilitating strategic decisions, planning and managing cross-functional business operations, technology projects, and driving successful implementations. She has helped create insightful, relevant analysis of Food & Beverage market reports and studies that include consumer market, retail, and manufacturer research perspective. She has also been involved in several bulletins in food magazines and journals.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Adaptive Shapewear Market Surges Towards US$ 6,605.2 Million by 2032

The global adaptive shapewear market is estimated at US$ 2,921.4 Million in 2022 and is projected to reach US$ 6,605.2 Million by 2032, with overall sales accelerating at 8.5% during the forecast period.

A type of underwear, which is adaptive, assists in looking slimmer and gives an improved body shape (compression of fats and skin folds). The present days` people are very self-conscious and SSocial position`s importance. Thus, achieving perfect body`s shape and conforming to beauty standards used in society play great role. For this reason, more and more people are wearing adaptive shapewear items these days. It will be further knocking on the market.

Shapewear helps people in achieving the ideal body shape without going to gym and dieting, gaining demand among ladies as well as gents. They also help people to deal with body deformities.

Shapewears are increasingly popular undergarments in the fashion business. These shaping underwear are designed for certain areas such as the stomach, waist, hips, and thighs. People can utilize the appropriate shapewear depending on their needs. Because shapewear instantaneously provides optimum figure and body configurations, the working population, particularly women looking for work-leisure attire, is acquiring and wearing it.

Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16238

More than 40% of women use shapewear to improve their waist and hip shape. Bodysuits, corsets, control tights, control panties, control slips, girdles, slimming camisoles, and many other types of shapewear for women have been introduced to the market, and are available in a variety of sizes to fit any type of body.

Technological improvements in the garment and fabric sectors are increasing adaptable shapewear innovation and, eventually, sales. Laser cutting and bonding technology aided in the removal of shapewear seams and fastenings that caused them to be uneven.

Because they are flexible and tensile, synthetic materials such as neoprene, spandex, and lycra are often utilized for shapewear. These enhanced fabrics breathe better, are softer, and have toning characteristics for excellent body sculpting. Because people became accustomed to wearing comfortable clothes during the COVID pandemic, manufacturers are focusing on improving the comfort of shapewear.

On the other hand, there are certain factors limiting the market expansion. These include the use of cheap and poor quality fabric by small manufacturers, availability of alternatives to the shapewear like activewear and sportswear, and health complications that can occur on excessive use of these shapewear.

Request the Full Report Methodology Now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16238

Key Takeaways from the Adaptive Shapewear Market Study

Based on product type, the adaptive pants and tops segment is anticipated to contribute a significant value share of around 53.2% during the forecast period.
By consumer orientation, women segment holds nearly 90% market share of the global market.
North America and Europe together hold the biggest share of the global adaptive shapewear market.
The U.S. adaptive shapewear market is poised to exhibit strong growth over the projection period.
Demand for adaptive shapewear products across India is likely to increase at a healthy pace over the next ten years.

“Adaptive shapewear are being used by people to improve their appearance, leaving a positive impact on the people as well as getting a confidence boost. The technological advancements and influence of social media are responsible for the increasing interest and sales in urban areas,” says an FMI Analyst.

Who is Winning?

Some key players in the adaptive shapewear market are YITTY, Shein, SKIMS, FFORA, Tommy Hilfiger, Zappos Adaptive, Slick Chicks, Care+Wear, IZ Adaptive, Buck & Buck, Izzy Camilleri, Able2Wear, PVH Corp., NBZ Apparel International, Adaptions By Adrian, Creation Comfort and others.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the adaptive shapewear market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the adaptive shapewear market based on product type (adaptive dresses, adaptive tops & pants, others), consumer orientation (men, women, unisex), closure type (zipper, hooks, pull-on/slip-on, others), and sales channel (wholesalers/distributors, hypermarkets/supermarkets, multi brand stores, independent stores, departmental stores, online retailers, other sales channels), across seven major regions.

Click on the Below Link to Buy this Report!
https://www.futuremarketinsights.com/checkout/16238

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube